Need Help?
Announcements
8 July 2026
MDPI’s Newly Launched Journals in June 2026
Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In June 2026, eleven new journals released their inaugural issues and two transferred journals released their first issue as part of MDPI, covering the subjects of environmental & earth sciences, chemistry & materials science, public health & healthcare, engineering, medicine & pharmacology, and biology & life sciences.
We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, enabling impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Xiaochuan Pan, Peking University, China |
public health research, practice, policy, and education; eco-health equity | |
|
|
Prof. Dr. Xin-Gao Gong Fudan University, China; Prof. Dr. Zhimei Sun Beihang University, China |
AI-enhanced theory & simulation; generative design & discovery; autonomous experimentation; AI for characterization; large language models and agents | |
|
|
Prof. Dr. Yong Liu, Wuhan University, China |
hydropower technology; renewable energy; water resources; optimization; rock and soil mechanics; power system stability | |
|
|
Prof. Dr. Giovanni Rezza, University Vita-Salute San Raffaele, Italy |
pandemic preparedness; public health; global outbreak dynamics and epidemiology; outbreak prediction and risk forecasting; one health approach; zoonotic and pre-pandemic vaccines | |
|
|
Prof. Dr. Brian Horton, University of Texas at Austin, USA |
stratigraphy; sedimentology; earth surface processes; basin evolution and tectonics; climate and paleoclimate | |
|
|
Prof. Dr. Yike Guo, Hong Kong University of Science and Technology, China |
artificial intelligence (AI); application of AI to engineering; Explainable AI (XAI); AI-driven design and optimization; AI for manufacturing and automation | view journal scope | submit an article |
|
|
Prof. Dr. Hei Wong, City University of Hong Kong, China |
novel semiconductor materials; advanced heterogeneous integration technologies; advanced characterization and testing techniques; heterogeneously integrated systems and applications; modeling and design automation| |
|
|
Prof. Dr. Michail Panagiotidis, Mississippi State University, USA |
plant-based medicines; natural products-based drug discovery; plant-based bioactive compounds; pharmacognosy; phytochemicals; pharmacokinetics | |
|
|
Prof. Dr. Khalid Meksem, Southern Illinois University, USA |
genome biotechnology; applied genomics; genetic engineering; agricultural biotechnology; medical biotechnology; data science and AI| |
|
|
Dr. Chenxi Wu, Chinese Academy of Sciences, China |
environmental cleanup; ecological restoration; environmental management and governance; environmental modeling and monitoring | |
|
|
Prof. Dr. Janusz Kozinski, Lakehead University, Canada |
renewable energy; sustainable agriculture; green innovation; climate change; artificial intelligence and environmental sustainability | |
|
Transferred Journals |
Editor(s)-in-Chief |
Journal Topics (Selected) |
|
|
Prof. Dr. Thomas Frese, Martin-Universität Halle-Wittenberg, Germany |
health services in primary care; integrated care models; quality and safety of care; coordination across primary and secondary care services; patient management; primary care clinical practice and interventions; clinical interventions delivered in primary care settings; |
|
|
Prof. Dr. Paul Gerson Unschuld, Geneva University Hospitals (HUG), Switzerland |
neurology, psychiatry, psychotherapy, and the neurosciences | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).
8 July 2026
Honoring the Top 1000 Reviewers for 2025
Peer review is the invisible foundation of academic progress. The 2025 MDPI Top Reviewers are some of the key experts who helped build it.
We are honored to recognize 1000 individuals from our global community of 210,000 reviewers across 67 countries and territories—chosen for their commitment to rigorous, constructive peer review and the consistency of their contributions throughout 2025.
The Top Reviewers provided constructive and impartial feedback that makes research stronger and more impactful, and we are grateful for it.
The names of these reviewers are listed below in alphabetical order by first name:
|
A. N. M. Mamun-Or-Rashid |
Han Wu |
Nijia Qian |
|
Abdallah Galal |
Hani Nasser Abdelhamid |
Nikola Petrović |
|
Abdeljabbar Ghanmi |
Hanstter Rezende |
Nina Mendez-Dominguez |
|
Abdelmalek Bellal |
Han-Tsung Wang |
Nora Ahmed |
|
Abdelnasser Abidli |
Hao Tang |
Nurcan Kilinc-Ata |
|
Abderrahim Ayad |
Haodong Chen |
Oğuzhan Çetindemir |
|
Abdulkadir Atalan |
Haoxuan Dong |
Oksana Kovtun |
|
Abid Ullah |
Hassan Barakat |
Oluwagbemiga Paul Agboola |
|
Adeney De Freitas Bueno |
Hassan Harb |
Omar Alsetoohy |
|
Agnieszka Synowiec |
Hebat-Allah Sarhan Tohamy |
Ömer Kaya |
|
Agnishwar Girigoswami |
Héctor Mora-Montes |
Omneya Attallah |
|
Agustín Ariño |
Hengkai Li |
Orestis M. Ioannidis |
|
Ahmadjan Muhammadhaji |
Hengrui Liu |
Oscar Arias-Carrion |
|
Ahmadreza Mohebbi |
Hiroshi Matsuyama |
Osmar Antonio Jaramillo Morales |
|
Ahmed Gad |
Ho Namgung |
Palash Mandal |
|
Ahmed Ghezal |
HoangNam Tran |
Panayiotis Iliakis |
|
Ahmed Mohamed Nabil Helaly |
Hongfen Zhu |
Pargam Vashishtha |
|
Ahmed Saad Rashed |
Hongzhi Shen |
Parisa Kaviani |
|
Ahmet İhsan Turan |
Hossein Lotfi |
Patrycja Kleczkowska |
|
Aidin Bordbar-Khiabani |
Huajin Li |
Paula Pinto |
|
Alain Manuel Chaple Gil |
Huayue Chen |
Paulius Skačkauskas |
|
Alan Gasiński |
Hui Lu |
Paulo Cezar Bastianello Campagnol |
|
Albena Doicheva |
Huseyin Cetin |
Pavel Kic |
|
Alberto Gallegos |
Hyeong-Geun Kim |
Pavlo Maruschak |
|
Alejandro Cano-Villagrasa |
Hyoungchul Shin |
Paweł Ciężkowski |
|
Aleksandr Bobrovskikh |
Ibrahim Mohamed |
Paweł Rydzewski |
|
Aleksandra Figurek |
Ibrahim Mosly |
Pedro Valdivia-Moral |
|
Aleksandra Jovanović |
Ibtissam Bakkouri |
Peng Chen |
|
Aleksandra Rybak |
Igor Schepetkin |
Pengle Cheng |
|
Alessandro Poggi |
Ilias Lazos |
Philippe Colomban |
|
Alessio Castagnoli |
Imen Barraj |
Pier Nicola Sergi |
|
Alexandre Pimenta |
Imran Ali |
Ping Zhu |
|
Alexey Andreychev |
Imtiaz Ahmad |
Piotr Legutko |
|
Alexey Beskopylny |
Ioannis A. Giantsis |
Piotr Lichota |
|
Alexis Murillo Carrasco |
Ioannis Vardiambasis |
Poya Sohrabi |
|
Alfredo Teixeira |
Irina Georgescu |
Pradeep Kumar Yadav |
|
Ali Abd El-Aty |
Isaac Adejumo |
Prashant Singh |
|
Ali Alshebami |
Isabel Legaz |
Prithviraj Nandigrami |
|
Ali Ercetin |
Isabel Maldonado |
Przemysław Podulka |
|
Ali Kandil |
Isabel Marques |
Qiang Peng |
|
Alireza Shoari |
Itamar Luís Gonçalves |
Qiang Yao |
|
Alok Tiwari |
Ivan Laktionov |
Qiaochu Li |
|
Aman Muhammad |
Ivan Šoša |
Qichang An |
|
Amgad Fahmy |
Ivan V. Semenyuta |
Qingqing Sun |
|
Amira Mohamed Idrees |
Izabela Zakrocka |
Rabii El Maani |
|
Amr Mohamed |
Jae Hwan Lee |
Radosław Balwierz |
|
Amroune Salah |
Jakub Ciazela |
Rafat Ghanamah |
|
Anastasia Ivanova |
Jale Minibas-Poussard |
Rajaram Rajamohan |
|
Anastasios Koulaouzidis |
Jamal Ayour |
Rajendra Rohokale |
|
Anatoli Popov |
James A. Bunce |
Raluca Isac |
|
András Molnár |
Janvier Habumugisha |
Raluca Mureşan |
|
André Luiz Missio |
Jarogniew Łuszczki |
Ramalingam Manikandan |
|
André Pinto |
Jasna Čanadanović Brunet |
Rashad EL-Sagheer |
|
André Rolim Baby |
Jean-Louis Pinault |
Rashid Dallaev |
|
Andres Camargo-Sanchez |
Jelena Petrović |
Ravish Patel |
|
Andrew Perry |
Jesús Bernardo Páez-Lerma |
Rehan Jamil |
|
Andrey Kuskov |
Jesus Jaquez-Muñoz |
Renzo Pepe-Victoriano |
|
Andrey Zamyatnin |
Jia Wang |
Ricardo Hernández-Martínez |
|
Andrii Velychkovych |
Jia Wen Li |
Ricardo Luiz Fernandes Bella |
|
Angeliki Papalou |
Jia-Bin Wu |
Ricardo Raimundo |
|
Anita Sejben |
Jianfeng Chen |
Rina Zviel-Girshin |
|
Anja Terzić |
Jiangmin Ding |
Ritthideach Yorsaeng |
|
Anna Kamenskikh |
Jiangxiong Zhu |
Robinson J. Herrera-Feijoo |
|
Anna Maria Kot |
Jiangyu Zhu |
Rocco Ditommaso |
|
Antanas Laurincikas |
Jianhua Ren |
Rocco Vitis |
|
Anton Tkachenko |
Jianjian Zheng |
Rodrigo Valenzuela |
|
António Miguel Monteiro |
Jianzhao Qi |
Roman Dmytryshyn |
|
António Portelada |
Jiazhen Zhang |
Roman Parovik |
|
Antonios Christou |
Jifu Li |
Ronit Sionov |
|
Antreas Kantaros |
Jingcai Zhang |
Ruben Rodríguez Elizalde |
|
Arash Kardani |
Joanna Kosałka-Węgiel |
Ružica R. Nikolić |
|
Arash Shams Taleghani |
João Carlos Caetano Simões |
Sadegh Ghaderi |
|
Armand Faganel |
Jonathan Soldera |
Salih Özer |
|
Artem Perepelitsyn |
Jongbeom Lim |
Saliha Karadayi-Usta |
|
Ashraf Ali |
Joon Hyuk Choi |
Salvatore Falanga Bolognesi |
|
Asif Ali Haider |
Jorge L. Mejía-Méndez |
Salvatore Simone |
|
Atila Kumbasaroglu |
José Ascención Martínez Álvarez |
Sandeep Kumar Chamoli |
|
Aurel Burciu |
José Antonio Suarez-Navarro |
Sandra Pascual-García |
|
Aynur Aliyeva |
José Carlos Vázquez-Parra |
Sanjin Kovacevic |
|
Ayushman Ramola |
Jose Lavres Junior |
Santiago Juan-Navarro |
|
Azizollah Khormali |
José Leija-Martínez |
Santosh Reddy Addula |
|
Baishu Guo |
José Luis Aguirre-Noyola |
Saravanan Ramasamy |
|
Baoqiang Liu |
José Ramiro Fernandes |
Sasa Radoslav Bubanj |
|
Bartłomiej Zieniuk |
José Rodrigues |
Saurabh Agarwal |
|
Bartosz Kruszewski |
Josef Yayan |
Sayed Saber |
|
Beata Dedicova |
Juan Gabriel Avina-Cervantes |
Sebastian Schnaubelt |
|
Behnam Mobaraki |
Juan Sebastián Fernández-Prados |
Sergei G. Gaidin |
|
Ben Ingram |
Juan Vielma-Perez |
Sergii Sagin |
|
Bernardo Tutikian |
Jui-Hsiang Lee |
Serife Balikci |
|
Bhupinder Kumar |
Junhe Yu |
Seweryn Lipiński |
|
Biao Luo |
Jun-Sheng Zhang |
Shadfar Davoodi |
|
Bin Wang |
Justin Nnaemeka Onyeukaziri |
Shamsaldeen Ibrahim Saeed |
|
Bin Yan |
K. S. Anandh |
Shanmugam Vignesh |
|
Binfeng Yin |
Kaibing Zhou |
Shaohua Lei |
|
Bing He |
Kakarla Ramakrishna |
Sheng Chang |
|
Bingnan Guo |
Kamil Henryk Nelke |
Shengqun Deng |
|
Bingzhe Zhang |
Kamran Shah |
Shigeru Kanemitsu |
|
Bishal Baniya |
Karina Teixeira Magalhães-Guedes |
Shijun Pan |
|
Bojan Stojanovic |
Karol Chilmon |
Shiquan Wang |
|
Bojana S. Stojanovic |
Karthik Kannan |
Shiva Shankar Reddy |
|
Bojana Vidovic |
Kasireddy Sudarshan |
Shuai Yuan |
|
Bozena Gajdzik |
Katarzyna Mądra-Gackowska |
Shun Yao |
|
Byoungwook Ahn |
Kavipriya Thangavel |
Shuo Liu |
|
Caio Santos Bonilha |
Keith Watts |
Siham Bakkouri |
|
Carlos Cerdán Santacruz |
Kelcie Slaton |
Silviu Beciu |
|
Carlos Marcuello Anglés |
Kesavan Nair |
Simone Galano |
|
Carolin Hannusch |
Ketan M. Ranch |
Simone Treccarichi |
|
Catalin Bulai |
Khrystyna Lipianina-Honcharenko |
Sina Sarfarazi |
|
Cátia Sousa |
Khursheed Ahmad |
Sinan Chen |
|
Changning Liu |
Kinga Korniejenko |
Sing-Chung Li |
|
Chanin Khomlaem |
Kiwon Lee |
Sivakumar Jeyarajan |
|
Chao Fu |
Konrad Szychowski |
Slađana Popović |
|
Chao Zheng |
Konstantin Alexandrovich Rybakov |
Slavica Miladinovic |
|
Chen Kim Lim |
Konstantinos Arsenopoulos |
Slobodanka Galovic |
|
Cheng Fang |
Koulla Parpa |
Sofoklis Stavros |
|
Cheng Li |
Kun Yang |
Somya Agrawal |
|
Chengling Lu |
Kuo-Chien Liao |
Song Yu |
|
Chenkang Liu |
Lambert Zixin Li |
Sotomi Ishihara |
|
Chigozie Andy Ngwaba |
László Orlóci |
Stanisław Pietrzyk |
|
Chih-Wei Zeng |
Laura Diaconu Maxim |
Stefanos Kourtis |
|
Chin-Feng Lin |
Laxman Subedi |
Stepan Dzhimak |
|
Ching-Ta Lu |
Leilei Wei |
Sudarshan Singh |
|
Chunxiao Li |
Leonidas Trakolis |
Suhan Zhang |
|
Corina Aurelia Zugravu |
Liang Zheng |
Süleyman Çınar Çağan |
|
Costel Plescan |
Lijana Maskeliūnaitė |
Swati Dahariya |
|
Cristian Ciobanescu |
Liliya Demidova |
Syed Asad Ali Zaidi |
|
Cristina Dumitru |
Lorena Del Carmen Espina Romero |
Szymon Suwała |
|
Dajun Liu |
Lorentz Jäntschi |
Tae Young Ko |
|
Dan Valeriu Voinea |
Luca Giacomelli |
Tao Ni |
|
Daniel Badulescu |
Luciana Rotaru |
Tarek Berghout |
|
Daniel Miron Brie |
Luis Miguel Pires |
Tatiana Fedotcheva |
|
Daniel Piotr Potaczek |
Luis O. Viteri Jumbo |
Tatiana V. Vygodina |
|
Daniel Sanin-Villa |
Lvyang Ye |
Tetsuya Tanioka |
|
Danijela Smiljanic |
Maconi Teixeira |
Theoharis Babanatsas |
|
David Michel De Oliveira |
Madina Isametova |
Thomas Roule |
|
Daxin Dong |
Magdalena Pietrzak |
Tiago Lima De Albuquerque |
|
Dejan Ćirin |
Mahendra Kumar Samal |
Tiziana Maria Sirangelo |
|
Dejan Vasovic |
Mahmoud Owais |
Tomáš Toporcer |
|
Deju Zhang |
Maja Hitl |
Tomasz Koczorowski |
|
Denis Stanescu |
Maksim Iavich |
Tomyslav Sledevič |
|
Derya Arslan |
Małgorzata Rataj |
Tudor Sorin Pop |
|
Di Tian |
Manal Fawzy |
Tuğba Kuru Çolak |
|
Dignesh Khunt |
Mansoor-Ali Vaali-Mohammed |
Tuo Zeng |
|
Dikshat Gupta |
Manuel De La Sen |
Tzu-Hurng Cheng |
|
Dimitrios Doukas |
Manuel Saba |
Vahdettin Demir |
|
Dimitrios Fanourakis |
Manuele Cesare |
Valdivino Alexandre De Oliveira Júnior |
|
Dina Khoudaer |
Marcelo Kaminski Lenzi |
Vanessa Bergamin Boralli |
|
Dmitriy Tverdyi |
Marcia Bastos Convento |
Vasile Razvan Filimon |
|
Dmitry Erokhin |
Márcio Vargas-Ramella |
Vasileios Greveniotis |
|
Domenico Rosa |
Marco Cavaco |
Vasily Lubashevskiy |
|
Dominika Gajdosikova |
Marco Eigenfeld |
Vasudeva Reddy Netala |
|
Dominika Guzek |
Marco Fogante |
Vesselin Gueorguiev |
|
Dong Wook Shin |
Marco Vincenzo Valente |
Vicente Borja Jaimes |
|
Dong Zhao |
Marcos Antonio Japiassu Resende Montes |
Vicente González-Prida |
|
Donghyun Lee |
Marcus Goncalves |
Victor Abiola Adepoju |
|
Dongwang Wu |
Marek Wozniak |
Vidyasrilekha Sanapalli |
|
Dongzhao Jin |
María Guadalupe Frías-De-León |
Vikas Mehta |
|
Douglas Watts |
Maria Pia Di Palo |
Vilmar Steffen |
|
Dragana Filipovic |
Marian Palcut |
Vincenzo Mirco La Fazia |
|
Duc Hung Pham |
Marianna Olivadese |
Vincezo Cuteri |
|
Dulani Meedeniya |
Marielena Saivish |
Virginia-Maria Rădulescu |
|
Dumitru Toader |
Marija R. Popović-Nikolić |
Vlad Stoian |
|
Dursun Zafer Seker |
Marina Konuhova |
Walaa Salah |
|
Eber Quintana-Obregón |
Marino Paroli |
Walter R. Schumm |
|
Eduarda Vieira |
Marios Christodoulou |
Wang Chun Kwok |
|
Eduardo Alvarez-Duarte |
Mariusz Bialecki |
Weber Da Silva Robazza |
|
Eduardo Fernandes |
Marko Bašković |
Wei Ling |
|
Edwin M. Pino-Vargas |
Marko Slavković |
Wei-Biao Liao |
|
Efraín Villamor Herrero |
Massimo Pacella |
Weichen Zhan |
|
Ehab Ali |
Matteo Angelo Fabris |
Weiwei Han |
|
Ehab AlShamaileh |
Matteo Conti |
Welson Bassi |
|
Ehsan Hosseini |
Matteo Pellegrini |
Wen Chen |
|
Ekaterina Lesovaya |
Maurizio Sabbatini |
Wiktor Stopyra |
|
Elcio Ferreira Dos Santos |
Maxim Polyakov |
Wilhelm Londono |
|
Elena Tchetina |
Mazen Al-Kheetan |
Wilhelm Mistiaen |
|
Elina Margarida Ribeiro Marinho |
Mehmet Das |
William Aperador |
|
Elnaz Amirahmadi |
Mehmet Palanci |
Wojciech Niemczyk |
|
Eloy Conde |
Melissa Anne Beryl Vogt |
Xiang Lei |
|
Elvira Rozhina |
Menaouar Berrehil El Kattel |
Xiang Zhang |
|
Emad A. Az-Zo'bi |
Meng Zhang |
Xiangchen Meng |
|
Emmanouil Georgios C. Tzanakakis |
Michael Halim |
Xiao Jian Tan |
|
En Lu |
Michal Stosiak |
Xiaohai Zheng |
|
Enrique Cervantes Pérez |
Michał Zarobkiewicz |
Xiaokang Ma |
|
Eqram Rahman |
Michele Paolantonio |
Xiaoxi Hu |
|
Erand Llanaj |
Mika Merviö |
Xin Li |
|
Eungi Kim |
Mikhail Akimov |
Xin Yang |
|
Evangelos Tsiaras |
Mikhail Arbatsky |
Xin Zhang (Henan Institute of Science and Technology) |
|
Fabio Massimo Oddi |
Mikhail Statkus |
Xin Zhang (Tianjin Normal University) |
|
Fahad Al Basir |
Milan Lal |
Xinfa Tang |
|
Faïçal Brini |
Milica Dimitrijevic Stojanovic |
Xinxin Zhao |
|
Fanglei Zhong |
Miłosz Huber |
Xinyan Peng |
|
Faseeulla Mohammad |
Ming Wu |
Xu Li |
|
Fayyaz Qureshi |
Minh Tam Schlosky |
Yang Shen |
|
Fazlurrahman Khan |
Mira Chitt |
Yanlin Shi |
|
Federico Minelli |
Mirela Jimborean |
Yanlong Ji |
|
Fei Han |
Mirela Lučan Čolić |
Yasir Rasool |
|
Fei Yu |
Miriam González-Afonso |
Yaxsier De Armas |
|
Fekete Mónika |
Mirjana Ocokoljić |
Yew Hoong Wong |
|
Fengwei Wang |
Miroslava Rakocevic |
Yile Chen |
|
Fernando França Cunha |
Mohamed A. Hassan |
Yinbo Gan |
|
Fernando Marson |
Mohamed Ibrahem Elhawy |
Yinghao Shan |
|
Fernando Monroy |
Mohamed-Amine Babay |
Yixin He |
|
Filipe Pereira |
Mohammad Aldossary |
Yong Zhang |
|
Flaviu Mihai Frigură-Iliasa |
Mohammad Ali Arjomand |
Yonggang Kim |
|
Florian Pape |
Mohammad Mofatteh |
Yoshiro Horai |
|
Florin Oancea |
Mohammad Nurul Matin |
Younho Han |
|
Francesco Cali |
Mohammad Younis Hajeer |
Youqiang Zhang |
|
Francesco Gagliardi |
Mohammed Abdulrasak |
Yuan Chen |
|
Francisco Delgado |
Mohammed Alnaim |
Yuanjie Deng |
|
Francisco E. M. Silveira |
Mohammed M. Gomaa |
Yuchen Wang |
|
Francisco Guillen-Grima |
Mohd Ismail Ibrahim |
Yue Cheng |
|
Francisco Rafael Trejo-Macotela |
Mohd Usman Mohd Junaidi |
Yue Ma |
|
Fredrick N. Eze |
Moisés Tolentino Bento Da Silva |
Yue Tan |
|
Fredy Hoyos Velasco |
Monika Michalska |
Yufei Gao |
|
Fuhaid Alshammari |
Mostafa Shooshtari |
Yunchao Tang |
|
Gabriel Marín Díaz |
Mothana Mustafa Gasaymeh |
Yuniel Méndez-Martínez |
|
Gabriel Sperandio Milan |
Mubarak A. Alanazi |
Yuri Tokarev |
|
Gabriela Ignat |
Mudasir Younis |
Yurii Syromyatnikov |
|
Gamal Ebrahim |
Muhammad A. Butt |
Yury V. Ilyushin |
|
Gang Hui |
Muhammad Jamil |
Yuyan Pan |
|
Gaydaa Al-Zohbi |
Muhammad Munir |
Zbigniew Raszewski |
|
George Karabatsos |
Muhammad Waseem |
Zbigniew Waśkiewicz |
|
Gerardo Fuentes-Vilugrón |
Muntean Calin |
Zeashan Khan |
|
Gerasimos Pagiatakis |
Murat Demiral |
Zeesham Abbas |
|
Giovani Telli |
Mussa Makran |
Zhao Li |
|
Gleb Zaitsev |
Mustafa Bora |
Zhen Zhang |
|
Golap Kalita |
Mustafa Zeybek |
Zheng Lu |
|
Gonzalo Emiliano Aranda-Abreu |
Muzaffar Iqbal |
Zheng Yuan |
|
Goran Marinkovic |
Nafiu Olanrewaju Ogunsola |
Zhengchang Wu |
|
Guangliang Xing |
Nagendra Verma |
Zhenhua Zhang |
|
Guanjun Yang |
Nam Deuk Kim |
Zhenyu Liu |
|
Guanzhou Ji |
Narayanaswamy Venketasubramanian |
Zhiguo Meng |
|
Guilherme Welter Wendt |
Natalia Kurhaluk |
Zhouli Liu |
|
Guillermo Berumen-Varela |
Natalija Čutović |
Zhuofu Liu |
|
Guna Sekhar Sajja |
Natesan Thirumalaivasan |
Zied Ben Hazem |
|
Guojie Xie |
Nebojša Jurišević |
Zihan Qu |
|
Hajer Ben Ammar |
Nevien Elhawat |
Zongwu Chen |
|
Hamid Ghazi Sulimany |
Nguyen Thi Thanh Binh |
Zorica Mojović |
|
Hamid Osman |
Nicolás Amigo |
(Note: we respected all privacy preferences, with part of nominees opting for limited attribution.)
2 July 2026
MDPI INSIGHTS: The CEO’s Letter #36 – Basel Anniversary Summit, 2025 Impact Factors & CiteScores, CSAL Partnership & ncRNA2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

Reflections from the MDPI 30th Anniversary Summit in Basel
On 4 June, we welcomed 30 Editors-in-Chief (EiCs) from across Europe, North America, and Asia-Pacific to A 66, MDPI’s former headquarters in Basel, for our 30th Anniversary Summit.
In the middle of the year that we celebrate 30 years since MDPI’s founding in 1996, the Summit provided an opportunity to reflect on our journey and recognize the academic community that has helped shape MDPI over the past three decades.
Designed as a small invitation-only event, the Summit brought together long-standing editorial leaders whose experience and perspectives continue to shape our journals. Throughout the day, one message emerged consistently: strong journals are built together, through partnership between publishers, editors, reviewers, and researchers.
MDPI at 30
During my opening presentation, I reflected on MDPI’s evolution from a single journal (Molecules) to a global Open Access (OA) publisher supporting more than 500 peer-reviewed journals, thousands of editors, and millions of researchers worldwide.
While our growth has been significant, our purpose remains unchanged: to help researchers communicate their work openly, efficiently, and responsibly.

I also took the opportunity to recognize that MDPI’s success has never been achieved alone. It has been built alongside our EiCs, Editorial Board Members, reviewers, authors, institutional partners, and colleagues around the world.
Agenda
The agenda combined moments for reflection, discussion, and direct engagement with our guests. The event was moderated by Damaris Critchlow (Editorial Engagement Manager, MDPI) and the program focused on dialogue rather than presentations alone, combining expert talks, panel discussions, and open forums covering:
- MDPI at 30: reflections and the road ahead
- Research integrity and editorial responsibility
- Partnerships and collaboration in publishing
- Editorial leadership and journal development
- Artificial intelligence and the future of scholarly publishing
|
|
|
|
|
|
|
|
|
|
Research Integrity and Editorial Responsibility
A key theme throughout the summit was the continued importance of research integrity and editorial independence. Tim Tait-Jamieson provided an overview of MDPI’s approach to publication ethics, emerging industry challenges, and ongoing investments in prevention, detection, and post-publication oversight. This was a key topic, as it created discussions on the evolving role of publishers, editors, and institutions in safeguarding the scientific record while maintaining transparency and trust.

Editors Panel: Building Journals and Communities
The EiC panel focused on the role of editorial leadership in developing journals and academic communities. Discussions highlighted the importance of active editorial boards, constructive peer review, community engagement, and maintaining quality as scholarly publishing continues to evolve. Thank you to our panelists: Dr. Ester Ballana (Viruses), Dr. Dilantha Fernando (Plants), and Dr. Ting Chi (Journal of Theoretical and Applied Electronic Commerce Research).

MDPI Panel: The Future of Scholarly Publishing
We also had a roundtable discussion on the future of scholarly publishing. Topics included:
- Artificial intelligence and its role in publishing workflows
- Technology and innovation in scholarly communication
- Research integrity and quality assurance
- The future of peer review
- Open Access and Open Science
- The evolving expectations of researchers, institutions, and funders
|
|
|
|
Recognizing Editorial Leadership
A highlight of the Summit was recognizing EiCs whose long-term leadership has helped strengthen both their journals and their research communities.
Through the Decade of Editorial Leadership Award and the Outstanding Editorial Impact Award, we celebrated individuals whose dedication has made a lasting contribution to scientific publishing.
|
|
|
|
As we look ahead to MDPI’s next chapter, partnerships with our editors and the wider academic community will remain central to everything we do.
Thank You
My sincere thanks to everyone who participated, and to the many colleagues whose planning and commitment made the Summit such a memorable event.
|
|
|
|
|
Impactful Research

2025 Impact Factors Released
June marked another important milestone, with the release of the 2025 Journal Citation Reports (JCR).
Learn more: https://www.mdpi.com/about/announcements/17055
This year:
- 330 MDPI journals received a Journal Impact Factor
- 254 journals increased their Impact Factor
- 29 journals received their first Journal Impact Factor
- 71% of ranked journals are now positioned in Q1 or Q2
- MDPI publications have now accumulated 25 million citations
While journal metrics should never be viewed as the sole measure of research quality, they remain an important indicator of journal visibility, community engagement, and scientific influence.
These achievements reflect the collective work of our Editors-in-Chief, Editorial Board Members, reviewers, authors, Publishing teams, and everyone involved in developing our journals.
Congratulations to every journal team that contributed to these results.
Inside MDPI

MDPI Journals Receive 2025 CiteScores
In June, Scopus published the 2025 CiteScores, providing another positive indication of the continued development of MDPI journals.
You can find more details about the 2025 CiteScore release here: Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
This year’s highlights include:
- 363 journals received a CiteScore
- 41 journals received a CiteScore for the first time
- 314 journals (86%) rank in Q1 or Q2
- 42 journals are now within the top 10% of their subject categories
Although no single metric defines journal quality, these results demonstrate the continued recognition and visibility of our journals across many research disciplines.
Particularly encouraging is the growing number of journals receiving their first CiteScore, reflecting years of sustained editorial development, successful indexing, and close collaboration between our Publishing teams, Indexing team, editors, and academic communities.
Thank you to everyone across MDPI whose daily work contributes to these achievements.
Coming Together for Science

Supporting Open Access in Switzerland: MDPI Renews Agreement with CSAL
I am pleased to share that MDPI has renewed its Open Access (OA) publishing agreement with the Consortium of Swiss Academic Libraries (CSAL), extending support for researchers across 24 Swiss institutions through our Institutional Open Access Program (IOAP).
As a Swiss-founded publisher, we are particularly proud to continue supporting Switzerland’s research community through long-term institutional partnerships that improve accessibility to Open Access publishing.
The renewal also coincides with the release of our 2025 Switzerland Country Report, highlighting continued national leadership in Open Science. Between 2021 and 2025, Switzerland maintained an OA publication rate of approximately 65–70%, while more than 14,000 Switzerland-affiliated papers have been published with MDPI since 2021.
“We are particularly proud to continue supporting Switzerland’s research community”
The announcement also received coverage across several leading international publishing and research news platforms, including STM, Research Information, EurekAlert!, Bytes Europe, and EdTech Innovation Hub, helping increase visibility for both the partnership and the broader discussion around OA.
My thanks to our IOAP, External Affairs, Communications, and Publishing teams, whose work continues to strengthen relationships with institutions around the world.
Closing Thoughts

Highlights from MDPI Conference ncRNA2026 in Leuven, Belgium (24–26 June)
From 24–26 June, MDPI hosted the ncRNA2026: From Molecular Mechanisms to Clinical Impact Conference in Leuven, Belgium.
The conference welcomed 125 participants from 22 countries and territories, providing an international forum for exchange across molecular biology, medicine, biotechnology, artificial intelligence, and translational research.

Bringing the Global Research Community Together
Over three days, participants exchanged ideas through:
- 4 Chair Talks
- 8 Invited Lectures
- 29 Selected Oral Presentations
- 51 Poster Presentations
Sessions covered topics including molecular biology, clinical applications, artificial intelligence, and emerging non-coding RNA research, creating a dynamic forum for scientific exchange.
|
|
|
Beyond the scientific program, the conference created opportunities for researchers, journal teams, sponsors, and academic partners to exchange ideas, build existing relationships, and create new collaborations across the global research community.
|
|
|
Our thanks to Conference Chairs Professors George Calin, Manuela Ferracin, Eleonora Leucci, and Isidore Rigoutsos, together with the invited speakers, for delivering an outstanding scientific program.
|
|
|
“By creating opportunities for researchers to exchange ideas, we continue to support the advancement of research worldwide”
Recognizing the Team
The conference also took place during an exceptional heatwave in Belgium, with temperatures reaching 38°C. Thanks to the excellent planning by the Conference team and collaboration with the venue, additional cooling measures and attendee support ensured that the event ran safely and successfully despite challenging conditions.
|
|
|
|
It is often these behind-the-scenes efforts that make the greatest difference to the participant experience. Thank you to everyone involved for your professionalism, flexibility, and commitment throughout the event.
Thank You
My sincere thanks to the Conference Chairs, invited speakers, sponsors, Editorial Office, Conference team, Marketing colleagues, volunteers, and everyone who contributed to making ncRNA2026 such a success.

As MDPI celebrates its 30th anniversary, events such as ncRNA2026 remind us that our contribution extends well beyond publishing journals. By creating opportunities for researchers to exchange ideas, establish collaborations, and build scientific communities, we continue to support the advancement of research worldwide.
Thank you for your continued dedication throughout another busy month, and I wish you all an enjoyable July!
Chief Executive Officer
MDPI AG
30 June 2026
Cancer Survivorship Awareness Month
June is Cancer Survivorship Awareness Month (also known as National Cancer Survivors Month)—a time when organizations and individuals around the world come together to honor the resilience of cancer survivors and raise awareness about the ongoing physical, emotional, and financial challenges they face. On this occasion, we acknowledge the strength of millions of individuals living with and beyond cancer. We also want to highlight some of the high-quality research on cancer survivorship published across MDPI’s oncology journal cluster, including Cancers, Current Oncology, Onco, Targets, and Precision Oncology. We hope that sharing these findings will provide valuable insights for everyone interested in advancing survivorship care, education, and long-term outcomes.

![]() |
![]() |
![]() |
![]() |
![]() |

“Revolutionizing Oncology Through AI: Addressing Cancer Disparities by Improving Screening, Treatment, and Survival Outcomes via Integration of Social Determinants of Health”
by Amit Kumar Srivastav, Aryan Singh, Shailesh Singh, Brian Rivers, James W. Lillard, Jr. and Rajesh Singh
Cancers 2025, 17(17), 2866; https://doi.org/10.3390/cancers17172866
“Barriers and Enablers to Engaging with Long-Term Follow-Up Care Among Canadian Survivors of Pediatric Cancer: A COM-B Analysis”
by Holly Wright, Sharon H. J. Hou, Brianna Henry, Rachelle Drummond, Kyle Mendonça, Caitlin Forbes, Iqra Rahamatullah, Jenny Duong, Craig Erker, Michael S. Taccone et al.
Curr. Oncol. 2025, 32(8), 427; https://doi.org/10.3390/curroncol32080427
“Effects of Exercise on Depression and Anxiety in Lung Cancer Survivors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Cuiqing Zhao, Xifeng Tao, Bingkai Lei, Yifan Zhang, Gen Li, Yuanyuan Lv and Laikang Yu
Curr. Oncol. 2025, 32(6), 304; https://doi.org/10.3390/curroncol32060304
“Nonregular Physical Activity and Handgrip Strength as Indicators of Fatigue and Psychological Distress in Cancer Survivors”
by Ilaria Pepe, Alessandro Petrelli, Francesco Fischetti, Carla Minoia, Stefania Morsanuto, Livica Talaba, Stefania Cataldi and Gianpiero Greco
Curr. Oncol. 2025, 32(5), 289; https://doi.org/10.3390/curroncol32050289
“Unraveling the Burden of Pancreatic Cancer in the 21st Century: Trends in Incidence, Mortality, Survival, and Key Contributing Factors”
by Jakob Zottl, Christian Günther Sebesta, Elena Tomosel, Marie-Christine Sebesta and Christian Sebesta
Cancers 2025, 17(10), 1607; https://doi.org/10.3390/cancers17101607
“The Influence of Poverty and Rurality on Colorectal Cancer Survival by Race/Ethnicity: An Analysis of SEER Data with a Census Tract-Level Measure of Persistent Poverty”
by Steven S. Coughlin, Meng-Han Tsai, Jorge Cortes, Malcolm Bevel and Marlo Vernon
Curr. Oncol. 2025, 32(5), 248; https://doi.org/10.3390/curroncol32050248
“From Diagnosis to Survivorship: The Role of Social Determinants in Cancer Care”
by Abiha Abdullah, Zeyu Liu and Michele Molinari
Cancers 2025, 17(7), 1067; https://doi.org/10.3390/cancers17071067
“Fraction of Genome Altered, Age, Microsatellite Instability Score, Tumor Mutational Burden, Cancer Type, Metastasis Status, and Choice of Cancer Therapy Predict Overall Survival in Multiple Machine Learning Models”
by Guillaume Mestrallet
Onco 2025, 5(1), 8; https://doi.org/10.3390/onco5010008
“Predicting Response to Treatment and Survival in Advanced Ovarian Cancer Using Machine Learning and Radiomics: A Systematic Review”
by Sabrina Piedimonte, Mariam Mohamed, Gabriela Rosa, Brigit Gerstl and Danielle Vicus
Cancers 2025, 17(3), 336; https://doi.org/10.3390/cancers17030336
“Survival Patterns and Prognostic Factors in Lip Cancer Patients: A 15-Year Single-Center Experience from Northeastern Brazil”
by Guilherme Carlos Beiruth Freire, Luiz Eduardo Rodrigues Juliasse, Salomão Israel Monteiro Lourenço Queiroz, Ruthinéia Diógenes Alves Uchôa Lins, Carlos Fernando Mourão and Bruno César de Vasconcelos Gurgel
Onco 2025, 5(1), 4; https://doi.org/10.3390/onco5010004

| “Cancer Survivorship: Transforming Challenges into Quality Living” Guest Editors: Dr. Christine Maheu and Dr. Tania Estapé Submission deadline: 31 August 2026 |
“Psychological Factors and Cancer Survivorship” Guest Editors: Dr. Deidre B. Pereira and Dr. Ashley P. Ghiaseddin Submission deadline: 30 September 2026 |
![]() |
![]() |
| “Cancer Rehabilitation: Innovations in Practice & Enhancing Survivorship Care” Guest Editors: Dr. David M. Langelier and Dr. Sara Parke Submission deadline: 15 November 2026 |
“Rehabilitation Opportunities in Cancer Survivorship” Guest Editors: Dr. Marie Carmen Valenza and Dr. Alejandro Heredia-Ciuro Submission deadline: 31 December 2026 |
![]() |
![]() |

![]() |
“Advances in Pediatric and Adolescent Psycho-Oncology” Edited by Dr. Lori Wiener and Dr. Amanda L. Thompson This is a Reprint of the Special Issue Advances in Pediatric and Adolescent Psycho-Oncology that was published in Cancers. |
17 June 2026
2025 Impact Factors Released
Impact Factors measure how often articles in scientific journals are cited—specifically, the average number of citations received in a given year by articles published in that journal over the previous two years, as tracked in the Web of Science. For researchers, the number answers a practical question: how often is work published in this journal being picked up and built upon?
The metric is assigned to the journal as a whole, not to individual articles. A high Impact Factor tells you something useful about a journal's place in its field; it tells you less about any single paper within it.
For a complementary, article-level view, MDPI lists an Altmetric score on each article page. Where the Impact Factor tracks academic citations, the Altmetric score captures broader online attention: how an article is being shared, discussed, and referenced beyond the journal literature. Together, they offer two different ways of asking the same question: is this research reaching people?
With 2025 CiteScores from Scopus published a few weeks ago, Clarivate has now released this year's Journal Impact Factors in the Journal Citation Reports (JCR).
254 MDPI Journals Saw a Rise in Impact Factor
This year's JCR include 330 MDPI journals across a wide range of disciplines. Of these, 231 journals are placed in the top 50% (Q1 or Q2) of their respective subject categories, a result that spans fields as different as materials science, public health, environmental studies, and mathematics. 78 journals hold a top-quartile position (Q1), and 33 journals have a JIF of 5.0 or above.
- 330 journals earned a Journal Impact Factor (JIF)
- 29 journals earned a first JIF
- 254 journals had an increase in JIF
- 71% of ranked journals are in Q1 or Q2
For the full metrics on any MDPI journal, visit our Web of Science journals overview page or a journal's individual statistics page.
29 MDPI Journals Received Their First Journal Impact Factor
A first Impact Factor is a confirmation for an emerging journal. It marks the point at which a journal has been publishing long enough, and cited broadly enough, to enter the formal record of scientific influence. For the research communities those journals serve, it signals that the work being published is being read and built upon.
This year, 29 MDPI journals received a Journal Impact Factor for the first time, across a range of emerging and established research areas. Each represents years of editorial development and peer review—recognized in 2026 for the first time in the JCR.
This is also part of a longer shift in how science gets indexed. When the Emerging Sources Citation Index (ESCI) launched in 2016, 24 MDPI journals were included. By 2024 that number had grown to over 200, reflecting a broader change in the visibility of open access publishing within major citation tracking systems, not just at MDPI but across the sector.
Open Access with Impact
MDPI journals have received a total of 25.2 million citations in Web of Science. That figure matters less as a measure of MDPI's reach and more as a measure of what happens when research is freely available: it gets found, read, and used. Open access is only meaningful if the work actually travels and citations are one indicator that it does.
More than 4.6 million authors have published with MDPI. That breadth, across disciplines, institutions, and geographies, is what makes open access at this scale worth doing.
Thank You to the MDPI Scholarly Community
These results belong to the people who do the actual work: the Editors-in-Chief who set the standards, the Editorial Board Members and reviewers who hold them, and the authors who choose open access for their research. The numbers in the Journal Citation Reports are the downstream effect of decisions made at the desk, in the review, and at submission. Thank you for making them.
Data: 2025 Journal Impact Factors, Journal Citation Reports™ (Clarivate, 2026)
11 June 2026
Onco Receives Its First CiteScore of 2.0
We are pleased to share that Onco (ISSN 2673-7523) has been assigned its first CiteScore of 2.0 in June 2026, following its inclusion in Scopus (Elsevier) in 2025. The CiteScore ranks the journal 295 out of 428 titles (Q3) in the “Oncology” category, an impressive achievement for a journal running in Volume 6.
You can find more statistics on our website.
The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.
This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Onco and its growing impact in oncology.
4 June 2026
Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.
CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.
The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.
Data Summary (2025 CiteScores)
- New Additions: 41 MDPI journals received a CiteScore for the first time.
- Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
- High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
- Elite Performance: 42 journals rank in the top 10% of their subject categories.
Portfolio Performance
Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.
With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.
Exceptional Achievements for Foods and Life
Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.
Journal Metrics and Beyond
Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.
Thank You
These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.
1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

30 Years of Open Science, Built Together
This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.
The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.
Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.
MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.
While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.
I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.
Thank you for being part of this journey.
Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)
From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.
The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:
- Chemical Biology for Drug Discovery
- Medicinal Chemistry Research Progress
- Natural Products in Drug Discovery
- AI-enabled Drug Discovery
- GPCR & Ion Channel Targeted Drug Development
- Innovative Proximity-Based Drug Modalities
- Biocatalysis for Natural Product & Drug Synthesis
The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.
|
|
|
Thanks to our Sponsors
MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules
During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.
They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.
Inside MDPI

Open Access Policies Continue to Accelerate Globally
One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.
Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.
For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.
“Expectations around openness and compliance continue to accelerate”
Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.
Recent Policy Developments
South Africa
In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”
The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.
Canada
In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.
The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”
Chile
Chile is a collaborative and engaged member of the global open access movement.
The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.
ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.
Openness Beyond Research
At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.
As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You
I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.
Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.
The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.
We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.
MDPI in Spain
Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.
A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:
- 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
- 211,200+ total publications (2021–2025), with 84% published open access.
- 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
- More than115,100 MDPI publications from Spanish institutions since 1996.
- More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
- 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
- Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.
Program Overview
What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:
- MDPI Introduction – Stefan Tochev (CEO).
- Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
- Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
- Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
- A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).
|
|
|
|
|
|
|
|
Panel Discussion
We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.
|
|
|
|
Themes from the Summit
Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:
- The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
- Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
- AI is rapidly changing scholarly communication and requires transparent and responsible governance.
- Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.
“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”
It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.
|
|
|
|
Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.
Thank You
Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.
|
|
|
|
|
|
|
|
As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.
Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)
This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.
The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge
Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:
- Antimicrobial resistance mechanisms
- One Health approaches to antimicrobial stewardship
- Discovery of novel antimicrobial agents
- Innovation in clinical strategies and treatment approaches
- Ethnopharmacology and emerging therapies
Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.
|
|
|
International Participation and Collaboration
One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.
The scientific program included:
- 2 keynote speakers
- 10 invited speakers
- 36 selected talks
- 78 posters
The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.
|
|
|
|
The Role of Conferences in Scholarly Communication
Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You
I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Chief Executive Officer
MDPI AG
29 May 2026
Journal Cluster of Oncology | Interview with Abigayle (Abbey) Vito—Poster Award Winner at 7th DNA Repair/Replication Structures & Cancer Conference
Ms. Abigayle (Abbey) Vito, a third-year graduate student in Dr. Bret Freudenthal’s lab at the University of Kansas Medical Center, won the poster award at the 7th DNA Repair/Replication Structures & Cancer Conference, sponsored by the Journal Cluster of Oncology, and we had the privilege of speaking with her. Below, she shares insights into her academic journey, research focus, and the motivation behind her landmark study.
1. Could you briefly introduce yourself and your main research focus within the broad area of DNA repair, replication structures, or cancer biology?
My name is Abigayle (Abbey) Vito, and I am a third-year graduate student in Dr. Bret Freudenthal’s lab at the University of Kansas Medical Center. My research focuses on understanding how DNA repair occurs within the complex chromatin environment of human cells. Much of the biochemical work that has laid the foundation for our knowledge of DNA repair has been performed on short DNA oligonucleotides. However, DNA in human cells is much more complex and is condensed into chromatin through the fundamental unit known as the nucleosome. My research goal is to understand how DNA repair, specifically base excision repair (BER), operates within chromatin. To address this goal, I utilize the nucleosome as a model system and use structural biology to elucidate the molecular mechanism that BER enzymes use to engage their substrates. This work fundamentally enhances our understanding of how DNA repair is carried out within human cells.
2. What do you think made your poster stand out—the scientific novelty, the clarity of the story, the visual presentation, or something else?
It was an incredible experience to attend a conference with so many structural biologists, from trainees to experts in the field. Based on the feedback I received during the poster session, I believe that my poster stood out for its clarity and the number of novel structures presented. I think, as structural biologists, we get very excited to see new structures from other researchers in the field because they can provide a lot of new insight into proteins that we are invested in understanding.
3. Any advice for early career researchers preparing their first poster?
The most important piece of advice that I have received about making a poster is that it is not necessary to present every piece of data that you have collected. It is much more impactful to have a visually appealing poster with a logical flow and only share the most important aspects of your story. Getting to the central point of your story quickly allows time for more meaningful conversations with audience members, which can lead to new perspectives on your research or experiments you may be struggling with.
4. Looking beyond the poster, what are the next steps for this research? Are you planning to follow up with a full paper?
This poster was only the beginning of a very exciting project! Along with structural data showing how BER enzymes engage their substrates, I am very interested in understanding how these enzymes locate their substrates to begin with. The nucleus of human cells contains over 3 billion base pairs of DNA, and these proteins face the extraordinarily difficult task of finding the specific lesion that they need to process. We are excited to use a single-molecule approach to investigate the mechanisms used by BER proteins to search for DNA damage. Looking further ahead, we hope to translate this into human cells to better understand how these enzymes protect against DNA-damaging agents that drive cancer.
5. Our journal has always been committed to promoting high-quality research in DNA repair/replication and cancer biology. Would you be interested in working with us? What kind of support would be most helpful for you in that process?
I would absolutely be interested in working with the journal! As my project develops, I hope to submit a research article encompassing both the structural and single-molecule findings from this work. Having a journal with a strong commitment to DNA repair and cancer biology would be a great fit for this story. As for support, having guidance through the submission and revision process would be most helpful. In particular, workshops that address the technical aspects of manuscript submission and the editorial/peer review process would be very beneficial for early-career researchers like myself.
26 May 2026
MDPI Canada & USA | Summary of an MDPI Subject Workshop—Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact
On 8 May 2026, MDPI Canada & USA welcomed over 40 researchers, clinicians, and oncology professionals to our Subject Workshop, “Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact”, held at the USC HSC Conference Center in Los Angeles, California.
![]() |
Our workshop host, Bob Vrooman, Head of Business Development at MDPI USA, opened the event and emphasized the importance of advancing cancer care. He introduced the workshop chair, Dr. W. Martin Kast, highlighting his achievements in immunology and cancer research. |
![]() |
Dr. W. Martin Kast welcomed attendees, emphasizing the transformative impact of cancer immunotherapy and the challenges that remain. |
![]() |
Then, MDPI Canada & USA’s Operating Director, Elvis Wang, emphasized the company's core values of transparency, service, and integrity. Furthermore, he explained the importance of collaboration in scientific research. |
The day’s presentations were full of exciting discussion as ten speakers discussed their research findings. These presenters included Dr. Abhinava Mishra, Dr. Alan L. Epstein, Dr. De-Chen Lin, Dr. Casey O’Connell, Dr. Henry K. Wong, Dr. Hossein Jadvar, Dr. Kawaljit Kaur, Dr. Lili Yang, Dr. W. Martin Kast, and Dr. Sonia Sharma.
The presentations included topics such as immune checkpoint blockade therapy, CAR-T and CAR-macrophage therapies, and the role of NK cells in cancer therapy. Furthermore, presentations focused on how epigenetic mutations reshape T-cell behavior.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
The second half of the day included presentations covering imaging treatment response criteria and multimodal single-cell analysis. Further presentations focused on the treatment of cutaneous T-cell lymphomas (CTCLs) and the development of therapeutic vaccines to treat HPV-associated cancers.
Dr. Sheridan Baker, a representative of MDPI, covered MDPI's role in supporting open science and MDPI’s publishing trends in oncology. His presentation allowed audience members to further understand how MDPI can support researchers working within a variety of research areas.
![]() |
![]() |
During the day’s proceedings, multiple Q&A sessions were held, allowing valuable engagement between speakers and attendees. These sessions were a highlight of the event and helped build a platform for meaningful scientific exchange.
![]() |
![]() |
![]() |
![]() |
Looking Ahead
The MDPI 2026 LA Subject Workshop “Cutting-Edge Advances in Cancer Immunology and Immunotherapy: From Basic Science to Clinical Impact” was a successful collaboration between MDPI and local academics. We are thankful to all attendees for their part in making this event possible and for contributing to its success.
We have received positive feedback regarding this event and look forward to continuing to host these Subject Workshops. For more updates regarding this event and other upcoming workshops, follow MDPI Canada on LinkedIn.
![]() |
![]() |































































































